// Healing & Recovery

BPC-157

Body Protection Compound-157 — a synthetic pentadecapeptide derived from a partial sequence of a protective protein found in human gastric juice.

Not FDA approved Primarily animal studies Actively researched

Mechanism

BPC-157 is a synthetic 15-amino-acid peptide fragment modeled on a sequence found in human gastric juice. In laboratory and animal research, it has been studied for its apparent ability to promote angiogenesis (new blood vessel formation) and support the repair of tendon, ligament, muscle, and gastrointestinal tissue.

Proposed mechanisms include upregulation of growth factor receptors involved in tissue repair (such as VEGFR2), modulation of the nitric oxide system, and interactions with the gut-brain axis. Most of this mechanistic evidence comes from cell-culture and rodent models rather than human trials.

What the evidence shows

Study typeModelReported finding
Preclinical (rat)Achilles tendon transectionAccelerated healing markers compared to untreated controls.
Preclinical (rat)Induced colitisReduced inflammatory markers and improved healing of gut lesions.
Preclinical (mouse)Muscle crush injuryFaster functional recovery of injured muscle tissue.
Human data—No large-scale, peer-reviewed randomized controlled trials in humans have been published to date; evidence is largely preclinical.
This table summarizes the general shape of published preclinical literature and does not represent an exhaustive systematic review. Always check the primary literature for current findings.

Safety & considerations

  • Not approved by the FDA, EMA, or MHRA for any human use; it is classified as a research chemical in most jurisdictions.
  • No robust long-term human safety data exists — most safety signals come from short-duration animal studies.
  • Because it is unregulated, product purity and identity from any given source cannot be independently verified without third-party lab testing.
  • Anyone considering its use for a personal health condition should discuss it with a licensed healthcare provider rather than relying on peptide-vendor marketing or online forums.

Sources

Linked for reference; inclusion is not an endorsement of any vendor or product. Always check the primary source for the most current data.
// Quick Facts
ClassSynthetic peptide fragment
Length15 amino acids
CategoryHealing & Recovery
FDA statusNot approved
Human trialsVery limited
Evidence baseMostly preclinical